Working… Menu

BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma (BEAT-meso)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03762018
Recruitment Status : Recruiting
First Posted : December 3, 2018
Last Update Posted : October 10, 2019
Hoffmann-La Roche
Information provided by (Responsible Party):
European Thoracic Oncology Platform

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 31, 2024
Estimated Study Completion Date : December 31, 2024